Handelen Medtronic - MDT CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.18 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.024068% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.001846% | ||||||||
| Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Medtronic PLC ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 77.43 |
| Open* | 77.32 |
| 1-Jaarlijkse Verandering* | -27.12% |
| Dagelijks bereik* | 77.32 - 79.4 |
| 52 wekelijks bereik | 75.77-114.31 |
| Weekgemiddelde volume (10 dagen) | 6.59M |
| Gemiddeld volume (3 maanden) | 128.91M |
| Marktkapitalisatie | 105.60B |
| P/E Ratio | 26.09 |
| Uitstaande Aandelen | 1.33B |
| Omzet | 30.77B |
| EPS | 3.04 |
| Dividend (opbrengst %) | 3.42699 |
| Beta | 0.73 |
| Volgende inkomsten datum | May 25, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Mar 24, 2023 | 79.29 | 2.00 | 2.59% | 77.29 | 79.45 | 76.93 |
| Mar 23, 2023 | 77.43 | -1.80 | -2.27% | 79.23 | 79.65 | 77.20 |
| Mar 22, 2023 | 79.81 | -0.93 | -1.15% | 80.74 | 81.90 | 79.81 |
| Mar 21, 2023 | 81.13 | 1.23 | 1.54% | 79.90 | 81.33 | 79.43 |
| Mar 20, 2023 | 79.49 | 0.90 | 1.15% | 78.59 | 79.70 | 78.25 |
| Mar 17, 2023 | 78.12 | -1.09 | -1.38% | 79.21 | 79.29 | 77.72 |
| Mar 16, 2023 | 79.20 | 2.02 | 2.62% | 77.18 | 79.33 | 77.04 |
| Mar 15, 2023 | 78.31 | 1.77 | 2.31% | 76.54 | 78.31 | 76.54 |
| Mar 14, 2023 | 77.73 | -1.32 | -1.67% | 79.05 | 79.25 | 76.95 |
| Mar 13, 2023 | 77.92 | 1.97 | 2.59% | 75.95 | 78.41 | 75.93 |
| Mar 10, 2023 | 76.62 | -1.10 | -1.42% | 77.72 | 78.02 | 76.02 |
| Mar 9, 2023 | 77.90 | -0.41 | -0.52% | 78.31 | 79.25 | 77.88 |
| Mar 8, 2023 | 78.30 | -1.16 | -1.46% | 79.46 | 79.51 | 77.93 |
| Mar 7, 2023 | 79.71 | -2.23 | -2.72% | 81.94 | 82.00 | 79.38 |
| Mar 6, 2023 | 81.83 | -1.49 | -1.79% | 83.32 | 83.74 | 81.34 |
| Mar 3, 2023 | 83.33 | 1.28 | 1.56% | 82.05 | 83.52 | 82.05 |
| Mar 2, 2023 | 82.13 | 0.75 | 0.92% | 81.38 | 82.49 | 81.07 |
| Mar 1, 2023 | 81.96 | -0.03 | -0.04% | 81.99 | 82.45 | 81.56 |
| Feb 28, 2023 | 82.70 | -0.43 | -0.52% | 83.13 | 83.61 | 82.45 |
| Feb 27, 2023 | 83.27 | 0.07 | 0.08% | 83.20 | 84.04 | 82.97 |
Medtronic Events
| Tijd (UTC) (UTC) | Land | Evenement |
|---|---|---|
| No events scheduled | ||
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totale inkomsten | 31686 | 30117 | 28913 | 30557 | 29953 |
| Inkomsten | 31686 | 30117 | 28913 | 30557 | 29953 |
| Kosten van opbrengsten, totaal | 9971 | 10355 | 9269 | 9064 | 9039 |
| Brutowinst | 21715 | 19762 | 19644 | 21493 | 20914 |
| Totale bedrijfskosten | 25934 | 25941 | 24535 | 24774 | 23351 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 10135 | 9776 | 9875 | 10232 | 9953 |
| Onderzoek & Ontwikkeling | 2746 | 2493 | 2331 | 2330 | 2256 |
| Depreciation / Amortization | 1733 | 1783 | 1756 | 1764 | 1823 |
| Rentekosten (inkomsten) - Operationeel nettobedrijfsresultaat | -117 | -224 | 226 | ||
| Ongebruikelijke uitgaven (inkomsten) | 1154 | 1219 | 1303 | 1342 | -172 |
| Other Operating Expenses, Total | 195 | 315 | 118 | 266 | 226 |
| Bedrijfsresultaat | 5752 | 4176 | 4378 | 5783 | 6602 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -541 | -425 | -379 | -676 | -938 |
| Overige, Netto | 306 | 144 | 56 | 90 | 11 |
| Netto inkomen voor belastingen | 5517 | 3895 | 4055 | 5197 | 5675 |
| Netto inkomen na belastingen | 5061 | 3524 | 4743 | 4662 | 5377 |
| Minderheidsbelang | -22 | -24 | -17 | -19 | 9 |
| Netto inkomen voor extra. Posten | 5039 | 3500 | 4726 | 4643 | 5386 |
| Netto inkomen | 5039 | 3606 | 4789 | 4631 | 3104 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 5039 | 3500 | 4726 | 4643 | 5386 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 5039 | 3606 | 4789 | 4631 | 3104 |
| Verwaterd Netto Inkomen | 5039 | 3606 | 4789 | 4631 | 3104 |
| Verwaterd Gewogen Gemiddelde Aandelen | 1351.4 | 1354 | 1351.1 | 1357.5 | 1368.2 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 3.72873 | 2.58493 | 3.49789 | 3.42026 | 3.93656 |
| Dividends per Share - Common Stock Primary Issue | 2.52 | 2.32 | 2.16 | 2 | 1.84 |
| Verwaterde Genormaliseerde Winst per Aandeel | 4.58931 | 3.55835 | 4.13123 | 4.31147 | 3.82352 |
| Totale buitengewone posten | 106 | 63 | -12 | -2282 | |
| Total Adjustments to Net Income | 0 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Totale inkomsten | 8089 | 7763 | 7847 | 7987 | 8188 |
| Inkomsten | 8089 | 7763 | 7847 | 7987 | 8188 |
| Kosten van opbrengsten, totaal | 2565 | 2433 | 2466 | 2507 | 2620 |
| Brutowinst | 5524 | 5330 | 5381 | 5480 | 5568 |
| Totale bedrijfskosten | 6418 | 6104 | 6284 | 7128 | 6583 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 2570 | 2521 | 2579 | 2510 | 2348 |
| Onderzoek & Ontwikkeling | 652 | 668 | 676 | 750 | 632 |
| Depreciation / Amortization | 435 | 432 | 431 | 436 | 446 |
| Ongebruikelijke uitgaven (inkomsten) | 53 | 113 | 111 | 833 | 338 |
| Other Operating Expenses, Total | 143 | -63 | 21 | 92 | 199 |
| Bedrijfsresultaat | 1671 | 1659 | 1563 | 859 | 1605 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -167 | -103 | -86 | -51 | -94 |
| Overige, Netto | 98 | 33 | 16 | 25 | 55 |
| Netto inkomen voor belastingen | 1602 | 1589 | 1493 | 833 | 1566 |
| Netto inkomen na belastingen | 1492 | 1483 | 1317 | 769 | 1366 |
| Minderheidsbelang | -6 | -4 | -6 | -6 | -6 |
| Netto inkomen voor extra. Posten | 1486 | 1479 | 1311 | 763 | 1360 |
| Netto inkomen | 1486 | 1479 | 1311 | 763 | 1360 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 1485 | 1480 | 1311 | 763 | 1360 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 1485 | 1480 | 1311 | 763 | 1360 |
| Verwaterd Netto Inkomen | 1485 | 1480 | 1311 | 763 | 1360 |
| Verwaterd Gewogen Gemiddelde Aandelen | 1343.9 | 1350.3 | 1355.3 | 1344.5 | 1357.9 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.10499 | 1.09605 | 0.96731 | 0.5675 | 1.00155 |
| Dividends per Share - Common Stock Primary Issue | 0.63 | 0.63 | 0.63 | 0.63 | 0.58 |
| Verwaterde Genormaliseerde Winst per Aandeel | 1.05737 | 1.11753 | 1.06914 | 1.32317 | 1.38596 |
| Total Adjustments to Net Income | -1 | 1 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 23059 | 22548 | 22031 | 21967 | 22980 |
| Geldmiddelen en kortetermijnbeleggingen | 10573 | 10817 | 10948 | 9848 | 11227 |
| Geldmiddelen & Equivalenten | 3714 | 3593 | 4140 | 4393 | 3669 |
| Korte Termijn Investeringen | 6859 | 7224 | 6808 | 5455 | 7558 |
| Totale Vorderingen, Netto | 5551 | 5462 | 4645 | 6222 | 5987 |
| Accounts Receivable - Trade, Net | 5551 | 5462 | 4645 | 6222 | 5987 |
| Total Inventory | 4616 | 4313 | 4229 | 3753 | 3579 |
| Other Current Assets, Total | 2319 | 1956 | 2209 | 2144 | 2187 |
| Total Assets | 90981 | 93083 | 90689 | 89694 | 91393 |
| Property/Plant/Equipment, Total - Net | 6267 | 6219 | 5755 | 4675 | 4604 |
| Property/Plant/Equipment, Total - Gross | 14219 | 13698 | 12571 | 10920 | 10259 |
| Accumulated Depreciation, Total | -7952 | -7479 | -6816 | -6245 | -5655 |
| Goodwill, Net | 40502 | 41961 | 39841 | 39959 | 39543 |
| Intangibles, Net | 15595 | 17740 | 19063 | 20560 | 21723 |
| Long Term Investments | 881 | 687 | 480 | 372 | 515 |
| Other Long Term Assets, Total | 4677 | 3928 | 3519 | 2161 | 2028 |
| Total Current Liabilities | 12394 | 8509 | 10366 | 8472 | 10084 |
| Accounts Payable | 2276 | 2106 | 1996 | 1953 | 1628 |
| Accrued Expenses | 5367 | 5681 | 4839 | 4885 | 5232 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 3742 | 11 | 2776 | 838 | 2058 |
| Other Current Liabilities, Total | 1009 | 711 | 755 | 796 | 1166 |
| Total Liabilities | 38430 | 41655 | 39952 | 39603 | 40673 |
| Total Long Term Debt | 20372 | 26378 | 22021 | 24486 | 23699 |
| Long Term Debt | 20316 | 26316 | 21976 | 24476 | 23678 |
| Capital Lease Obligations | 56 | 62 | 45 | 10 | 21 |
| Deferred Income Tax | 884 | 1028 | 1174 | 1278 | 1423 |
| Minority Interest | 171 | 174 | 135 | 121 | 102 |
| Other Liabilities, Total | 4609 | 5566 | 6256 | 5246 | 5365 |
| Total Equity | 52551 | 51428 | 50737 | 50091 | 50720 |
| Common Stock | 0.13307 | 0.13454 | 0.13411 | 0.13407 | 0 |
| Additional Paid-In Capital | 24566 | 26319 | 26165 | 26532 | 28127 |
| Retained Earnings (Accumulated Deficit) | 30250 | 28594 | 28132 | 26270 | 24379 |
| Unrealized Gain (Loss) | -209 | 92 | 0 | -45 | -194 |
| Other Equity, Total | -2056.13 | -3577.13 | -3560.13 | -2666.13 | -1592 |
| Total Liabilities & Shareholders’ Equity | 90981 | 93083 | 90689 | 89694 | 91393 |
| Total Common Shares Outstanding | 1330.74 | 1345.4 | 1341.07 | 1340.7 | 1354.22 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 23059 | 23303 | 22731 | 22434 | 22548 |
| Geldmiddelen en kortetermijnbeleggingen | 10573 | 11221 | 10669 | 10595 | 10817 |
| Geldmiddelen & Equivalenten | 3714 | 3479 | 2900 | 3004 | 3593 |
| Korte Termijn Investeringen | 6859 | 7742 | 7769 | 7591 | 7224 |
| Totale Vorderingen, Netto | 5551 | 5446 | 5493 | 5431 | 5462 |
| Accounts Receivable - Trade, Net | 5551 | 5446 | 5493 | 5431 | 5462 |
| Total Inventory | 4616 | 4514 | 4349 | 4288 | 4313 |
| Other Current Assets, Total | 2319 | 2122 | 2220 | 2120 | 1956 |
| Total Assets | 90981 | 91804 | 91756 | 91802 | 93083 |
| Property/Plant/Equipment, Total - Net | 5413 | 5251 | 5188 | 5162 | 6219 |
| Property/Plant/Equipment, Total - Gross | 13365 | 13074 | 12978 | 12808 | 12700 |
| Accumulated Depreciation, Total | -7952 | -7823 | -7790 | -7646 | -7479 |
| Goodwill, Net | 40502 | 41346 | 41612 | 41720 | 41961 |
| Intangibles, Net | 15595 | 16078 | 16523 | 16890 | 17740 |
| Long Term Investments | 881 | 827 | 781 | 692 | 687 |
| Other Long Term Assets, Total | 5531 | 4999 | 4921 | 4904 | 3928 |
| Total Current Liabilities | 12394 | 8927 | 7803 | 7764 | 8509 |
| Accounts Payable | 2276 | 1985 | 1917 | 1864 | 2106 |
| Accrued Expenses | 5672 | 5694 | 5403 | 5553 | 5681 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 3742 | 865 | 16 | 6 | 11 |
| Other Current Liabilities, Total | 704 | 383 | 467 | 341 | 711 |
| Total Liabilities | 38430 | 39262 | 39765 | 40316 | 41655 |
| Total Long Term Debt | 20372 | 24290 | 25607 | 25958 | 26378 |
| Long Term Debt | 20316 | 24232 | 25548 | 25898 | 26316 |
| Capital Lease Obligations | 56 | 58 | 59 | 60 | 62 |
| Deferred Income Tax | 884 | 968 | 1024 | 1054 | 1028 |
| Minority Interest | 171 | 171 | 168 | 178 | 174 |
| Other Liabilities, Total | 4609 | 4906 | 5163 | 5362 | 5566 |
| Total Equity | 52551 | 52542 | 51991 | 51486 | 51428 |
| Common Stock | 0.13307 | 0.13426 | 0.13449 | 0.13447 | 0.13454 |
| Additional Paid-In Capital | 24566 | 25814 | 26059 | 26184 | 26319 |
| Retained Earnings (Accumulated Deficit) | 30250 | 29607 | 28974 | 28511 | 28594 |
| Unrealized Gain (Loss) | -209 | -22 | 48 | 104 | 92 |
| Other Equity, Total | -2056.13 | -2857.13 | -3090.13 | -3313.13 | -3577.13 |
| Total Liabilities & Shareholders’ Equity | 90981 | 91804 | 91756 | 91802 | 93083 |
| Total Common Shares Outstanding | 1330.74 | 1342.57 | 1344.86 | 1344.67 | 1345.4 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | 5062 | 3630 | 4806 | 4650 | 3095 |
| Geldmiddelen uit Operationele Activiteiten | 7347 | 6240 | 7234 | 7007 | 4684 |
| Geldmiddelen uit Operationele Activiteiten | 2707 | 2702 | 2663 | 2659 | 2644 |
| Deferred Taxes | -604 | -422 | -1315 | -304 | -919 |
| Niet-Geldelijke Posten | 1070 | 1031 | 1019 | 1082 | 37 |
| Cash Taxes Paid | 996 | 1250 | 878 | 1558 | 2542 |
| Contant Betaalde Rente | 540 | 582 | 643 | 973 | 1147 |
| Veranderingen in het Operationeel Kapitaal | -888 | -701 | 61 | -1080 | -173 |
| Geldmiddelen uit Investeringsactiviteiten | -1659 | -2866 | -3203 | -774 | 5858 |
| Kapitaaluitgaven | -1368 | -1355 | -1213 | -1134 | -1068 |
| Overige Cash Flow investeringsposten, Totaal | -291 | -1511 | -1990 | 360 | 6926 |
| Geldmiddelen uit Financieringsactiviteiten | -5336 | -4136 | -4198 | -5431 | -11954 |
| Financiering van Cash Flow Posten | 163 | -268 | -81 | 14 | -50 |
| Total Cash Dividends Paid | -3383 | -3120 | -2894 | -2693 | -2494 |
| Uitgifte (Aflossing) van aandelen, netto | -2115 | -178 | -664 | -1885 | -1768 |
| Uitgifte (Aflossing) van Schulden, Netto | -1 | -570 | -559 | -867 | -7642 |
| Wisselkoerseffecten | -231 | 215 | -86 | -78 | 114 |
| Nettowijziging in Geldmiddelen | 121 | -547 | -253 | 724 | -1298 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 5062 | 3570 | 2086 | 769 | 3630 |
| Cash From Operating Activities | 7347 | 5289 | 3061 | 1292 | 6240 |
| Cash From Operating Activities | 2707 | 2019 | 1347 | 671 | 2702 |
| Deferred Taxes | -604 | -234 | -78 | -11 | -422 |
| Non-Cash Items | 1070 | 943 | 888 | 715 | 1031 |
| Cash Taxes Paid | 996 | 842 | 615 | 249 | 1250 |
| Cash Interest Paid | 540 | 295 | 280 | 63 | 582 |
| Changes in Working Capital | -888 | -1009 | -1182 | -852 | -701 |
| Cash From Investing Activities | -1659 | -1930 | -1493 | -784 | -2866 |
| Capital Expenditures | -1368 | -979 | -649 | -378 | -1355 |
| Other Investing Cash Flow Items, Total | -291 | -951 | -844 | -406 | -1511 |
| Cash From Financing Activities | -5336 | -3387 | -2210 | -1055 | -4136 |
| Financing Cash Flow Items | 163 | -52 | -46 | -4 | -268 |
| Total Cash Dividends Paid | -3383 | -2540 | -1693 | -846 | -3120 |
| Issuance (Retirement) of Stock, Net | -2115 | -794 | -470 | -204 | -178 |
| Issuance (Retirement) of Debt, Net | -1 | -1 | -1 | -1 | -570 |
| Foreign Exchange Effects | -231 | -87 | -51 | -42 | 215 |
| Net Change in Cash | 121 | -115 | -693 | -589 | -547 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.3573 | 124491788 | 1243126 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.4559 | 72586912 | 3184703 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.512 | 60029051 | 1039338 | 2022-12-31 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 2.548 | 33898890 | 1194858 | 2022-12-31 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.2442 | 29857047 | -1240263 | 2022-12-31 | LOW |
| Capital Research Global Investors | Investment Advisor | 2.1658 | 28814669 | 37199 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0461 | 27222300 | 423715 | 2022-12-31 | LOW |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.2071 | 16059161 | 936343 | 2022-12-31 | LOW |
| Managed Account Advisors LLC | Investment Advisor | 1.1558 | 15377670 | -3007005 | 2022-12-31 | LOW |
| JP Morgan Asset Management | Investment Advisor | 1.0919 | 14527410 | -214609 | 2022-12-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0274 | 13668496 | 626225 | 2022-12-31 | LOW |
| DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.9969 | 13263284 | 1797223 | 2022-12-31 | LOW |
| Sanders Capital, LLC | Investment Advisor | 0.9515 | 12658542 | -199168 | 2022-12-31 | LOW |
| American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.9013 | 11990457 | 545538 | 2022-12-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.8866 | 11794893 | -258903 | 2022-12-31 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7999 | 10641725 | 2548341 | 2022-12-31 | LOW |
| Invesco Advisers, Inc. | Investment Advisor | 0.7763 | 10328189 | 1336047 | 2022-12-31 | LOW |
| AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 0.7543 | 10034945 | 194817 | 2022-12-31 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7234 | 9624338 | -453649 | 2022-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.7002 | 9315796 | 255281 | 2022-12-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group500K+
Handelaren
92K+
Actieve klanten per maand
$53M+
Maandelijks beleggingsvolume
$30M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
Handelscommissie
0
- 1:1
Hefboom
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Medtronic Company profile
Over Medtronic
Medtronic plc is een wereldwijd technologiebedrijf op het gebied van gezondheidszorg. Het bedrijf ontwikkelt, produceert en verkoopt medische apparatuur en technologieën voor ziekenhuizen, artsen, clinici en patiënten. De bedrijfssegmenten zijn Cardiovasculair, Medisch-chirurgisch, Neurowetenschappelijk en Diabetes. Tot de cardiovasculaire producten behoren pacemakers, insteekbare hartmonitoren en cardiale resynchronisatietherapieapparatuur. Medisch-chirurgische producten omvatten patiëntenzorg van diagnose tot herstel, met de nadruk op ziekten van het maagdarmkanaal, de longen, het bekkengebied, de nieren, zwaarlijvigheid en te voorkomen complicaties. Tot de neurowetenschapsproducten behoren diverse ruggegraatsimplantaten, bottransplantaatvervangers, biologische producten, beeldgestuurde chirurgie en intraoperatieve beeldvormingssystemen. Diabetesproducten omvatten insulinepompen, systemen voor continue glucosemonitoring (CGM), verbruiksartikelen en slimme insulinepennen. De onderneming levert ook PROPEL en SINUVA, bioabsorbeerbare, steroïd-eluting implantaten voor sinuspatiënten.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
20 On Hatch
Hatch Street Lower
DUBLIN
DUBLIN
IE
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 500.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen